RadNet, Inc. (NASDAQ:RDNT) shares moved down -1.06% in last trading session and ended the day at $5.62. RDNT Gross Margin is 19.80% and its has a return on assets of 1.40%. RadNet, Inc. (NASDAQ:RDNT) quarterly performance is -6.80%.
Gencor Industries Inc. (NASDAQ:GENC) ended the last trading day at $12.49. Company weekly volatility is calculated as 4.12% and price to cash ratio as 1.25. Gencor Industries Inc. (NASDAQ:GENC) showed a weekly performance of -0.87%.
Zacks Investment Research upgraded shares of RadNet Inc. (NASDAQ:RDNT) from a hold rating to a buy rating in a research note issued to investors on Wednesday morning, MarketBeat Ratings reports. Zacks Investment Research currently has $6.25 target price on the stock.
On 10 February, Gencor Industries, Inc. (NASDAQ:GENC) announced net revenues increased 111% to $13.3 million for the quarter ended December 31, 2015 compared to $6.3 million for the quarter ended December 31, 2014. Gross margins increased significantly from 5.5% for the quarter ended December 31, 2014 to 24.8% for the quarter ended December 31, 2015, due to improved productivity, increased revenues and cost absorption, process improvements, and lower commodity prices. Product engineering and development expenses increased $53,000 to $382,000 for the quarter ended December 31, 2015 due to increased staffing and payroll. Selling, general and administrative expenses increased $135,000 or 8.2% to $1,785,000 for the quarter ended December 31, 2015. Sales commissions and other operating expenses increased due to the higher revenues.
On 18 February, Safeguard Scientifics, Inc. (NYSE:SFE) shares moved down -2.15% and was closed at $12.30. SFE EPS growth in last 5 year was -15.80%. Safeguard Scientifics, Inc. (NYSE:SFE) year to date (YTD) performance is -15.23%.
Safeguard Scientifics, Inc. (NYSE:SFE) will release its financial results for the fourth quarter and year-ended December 31, 2015 prior to market open on Thursday, March 3, 2016.
Blucora, Inc. (NASDAQ:BCOR) shares moved up 1.59% in last trading session and ended the day at $6.37. BCOR Gross Margin is 50.40% and its has a return on assets of -6.00%. Blucora, Inc. (NASDAQ:BCOR) quarterly performance is -38.93%.
On 11 February, it was reported Blucora, Inc. (NASDAQ:BCOR) expects revenues to be between $444.0 million and $462.5 million, Adjusted EBITDA to be between $86.0 million and $91.5 million, Non-GAAP income from continuing operations to be between $40.6 million and $47.5 million, or $0.96 to $1.12 per diluted share, and GAAP loss from continuing operations to be between $(7.5) million and $(2.2) million, or $(0.18) to $(0.05) per diluted share.
Synthetic Biologics Inc. (NYSEMKT:SYN) caters to the Healthcare space. Its weekly performance is 23.76%. On the last day of trading company shares ended up at $1.25. Synthetic Biologics Inc. (NYSEMKT:SYN) distance from 50-day simple moving average (SMA50) is -33.59%.
Synthetic Biologics, Inc. (NYSE MKT: SYN), announced that the U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance for a patent application which covers the use of a variety of compounds, including the active agent of SYN-010, the Company’s proprietary, modified-release formulation of lovastatin lactone designed to treat a major underlying cause of irritable bowel syndrome with constipation (IBS-C).